Factorial Partners’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-56,000
Closed -$939K 81
2024
Q2
$939K Sell
56,000
-20,200
-27% -$325K 0.58% 55
2024
Q1
$985K Hold
76,200
0.56% 62
2023
Q4
$882K Sell
76,200
-13,000
-15% -$147K 0.56% 59
2023
Q3
$1.14M Buy
89,200
+7,000
+9% +$99.2K 0.83% 49
2023
Q2
$1.13M Buy
82,200
+3,500
+4% +$50.1K 0.78% 51
2023
Q1
$1.21M Buy
78,700
+3,000
+4% +$45.8K 0.91% 41
2022
Q4
$1.02M Sell
75,700
-10,000
-12% -$134K 0.78% 51
2022
Q3
$1.14M Buy
85,700
+13,000
+18% +$224K 0.99% 39
2022
Q2
$1.39M Buy
72,700
+2,000
+3% +$37.9K 1.13% 37
2022
Q1
$1.41M Buy
70,700
+200
+0.3% +$4.04K 0.97% 45
2021
Q4
$1.44M Buy
70,500
+12,500
+22% +$267K 0.95% 39
2021
Q3
$1.25M Hold
58,000
0.85% 43
2021
Q2
$1.68M Sell
58,000
-1,000
-2% -$27K 1.13% 35
2021
Q1
$1.44M Buy
59,000
+11,000
+23% +$248K 1.01% 35
2020
Q4
$932K Hold
48,000
0.78% 45
2020
Q3
$835K Buy
48,000
+500
+1% +$10.7K 0.85% 41
2020
Q2
$1.25M Hold
47,500
1.37% 28
2020
Q1
$1.15M Sell
47,500
-43,500
-48% -$1.06M 1.53% 20
2019
Q4
$2.11M Buy
91,000
+47,500
+109% +$1.1M 0.97% 30
2019
Q3
$928K Buy
43,500
+10,500
+32% +$288K 0.89% 34
2019
Q2
$1.05M Buy
33,000
+3,500
+12% +$110K 1.01% 32
2019
Q1
$974K Buy
29,500
+2,700
+10% +$84K 0.92% 36
2018
Q4
$862K Buy
26,800
+6,000
+29% +$226K 0.9% 37
2018
Q3
$892K Buy
20,800
+300
+1% +$14.2K 0.77% 47
2018
Q2
$944K Sell
20,500
-6,400
-24% -$283K 0.84% 41
2018
Q1
$1.07M Sell
26,900
-3,100
-10% -$115K 0.98% 34
2017
Q4
$1M Buy
+30,000
New +$1.07M 0.93% 37

Other funds holding PAHC

Factorial Partners's PAHC Position: Q3 2024 in Review

Factorial Partners sold out of Phibro Animal Health (PAHC) in Q3 2024, closing a stake of 56,000 shares — an estimated $939K sold.

Factorial Partners first reported a position in PAHC in Q4 2017 and held it in 27 quarters. The position peaked at $2.11M in Q4 2019. 147 funds tracked by Wall St. Rank hold PAHC as of Q3 2024.

  • Factorial Partners reported no remaining Phibro Animal Health position as of Q3 2024 after selling out during the quarter.
  • Factorial Partners sold 56,000 Phibro Animal Health shares in Q3 2024, an estimated $939K.
  • Factorial Partners first reported a position in Phibro Animal Health in Q4 2017 and held it in 27 quarters.
  • Factorial Partners's Phibro Animal Health position peaked at $2.11M in Q4 2019.
  • 147 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2024.

Based on Factorial Partners's 13F filing for Q3 2024, filed 8 Nov 2024.